Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

(John is a composite character, based on the experiences of real-life patients.) John was diagnosed with bladder cancer using ...

When it comes to cancer symptoms, we are often given advice on which signs to look out for. However, there is a type of ...

There are about 80,000 new cases of bladder cancer every year in the US alone. About one-third of cases are diagnosed at late ...

Investigators assessed whether intravesical BCG is necessary for patients with high-grade T1 nonmuscle-invasive bladder cancer who have unremarkable histology on the second transurethral resection.

A recent study reveals that extended lymphadenectomy offers no survival advantage over standard lymphadenectomy for patients ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

A bladder ultrasound gives providers clues about how the bladder expands and holds urine. This article lists conditions ...

The promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment ...